NS-0200
AssetAlso called NS-0200-0.5, NS-0200-1.0
- Stage
- Phase 2
- Modality
- Not known
- Target
- Not known
- 2
- Indications
- 207
- Trials
- 1
- Developer
Trial NCT07647003 is still running. Trial NCT07647003 started on Oct 15, 2026. clinicaltrials.gov
Indications
2Hypertension
Phase 2, Not yet recruiting, NCT07647003, clinicaltrials.gov, Oct 24, 2026
Metabolic dysfunction-associated steatotic liver disease
Phase 2, Completed, NCT02546609, clinicaltrials.gov, Oct 31, 2026
In the full profile
- Target and mechanism1
- Owner and partners1
- Trials207
- Evidence for its targets1
- Competitors12
- Signals4
Every asset’s record: target, stage, trials and the evidence behind it.